Tag: Heart Failure
AHA: Neurohormonal Blockade Beneficial for Patients With LVAD
At four years, survival better among patients with LVADs receiving any NHB medication at six months
AHA: Impact of Valsartan Recall Examined for Ontario, Canada
Immediate increase in emergency department visits for hypertension seen after generic valsartan recall
AHA: Vitamin D, Omega-3 Do Not Cut Heart Failure Hospitalization
However, marine n-3 supplementation appears to reduce recurrent heart failure hospitalization
2011 to 2017 Saw Increase in Heart Disease Deaths in the U.S.
Despite decrease in age-adjusted mortality rate, more heart disease deaths seen with aging of population
Racial Inequity Seen for Admission to Cardiology for Heart Failure
Black and Latinx patients have lower rates of admission to cardiology service, as do women, >75s
Lean-Fat Individuals Have Worst Outcome in Heart Failure
Asian patients with low BMI, high WHtR have higher prevalence of diabetes, worse QoL, worse outcomes
Risk Tool Can Predict Heart Failure in Patients With Diabetes
AI model integrates readily available clinical, laboratory, and electrocardiographic data
Uptitration of Drugs Varies With Target Dosage in Chronic HF
When target is higher versus lower dosage, uptitration stops further from recommended dosage
Dapagliflozin Lowers Risk for Worsening Heart Failure
Findings seen among patients with heart failure, reduced ejection fraction, irrespective of diabetes
SGLT2 Inhibitors Linked to Lower Risk for Heart Failure
Risk lower for HF, but not major CV events, compared with new users of DPP4 inhibitors
